Global Molecular Diagnostics Market 2016-2020

  • ID: 3678074
  • Report
  • Region: Global
  • 64 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • AsuraGen
  • EKF Molecular Diagnostics
  • HTG Molecular
  • Mindray
  • Ras Lifesciences
  • MORE
About Molecular Diagnostics

The traditional trial and error techniques that were used in the field of medicine are now being replaced by accurate, safe, marker-assisted, molecular-guided treatments. Molecular diagnostics is one such technique. This is a technique that involves measurement and analysis of DNA and RNA at the molecular level to detect changes in biochemical pathways.

The aim of performing these tests is to determine the location of a disease and its activity. Wide scope of application, specificity, and quick turnaround time are factors that are contributing to its importance in the IVD market.

The analysts forecast the global molecular diagnostics market to grow at a CAGR of 10.38% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global molecular diagnostics market for 2016-2020. To calculate the market size, revenue generated from the sales of equipment such as automated real-time PCR, mass spectroscopy, and DNA sequencing and DNA microarray diagnostic devices, consumables, and reagents is considered.

The market is divided into the following segments based on geography:

- Americas
- APAC
- EMEA

The report, Global Molecular Diagnostics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

- Abbott Laboratories
- Hologic Inc.
- Qiagen
- Roche Diagnostics (a division of F. Hoffmann-La Roche Ltd.)
- Siemens Healthcare GmbH

Other prominent vendors

- AsuraGen
- Ahram Biosystem
- Analytik Jena
- BD
- Bio-Rad
- EKF Molecular Diagnostics
- EMD Millipore
- HTG Molecular
- InBios International
- Maxim Biomedical
- Mindray
- Myriad Genetics
- Ortho Clinical Diagnostics
- Ras Lifesciences
- Trivitron Healthcare
- ThermoFisher Scientific

Market drivers

- Key to cost-effective diagnosis of cancer

Market challenges

- Reimbursement issues

Market trends

- Growth of theranostics

Key questions answered in this report:

- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • AsuraGen
  • EKF Molecular Diagnostics
  • HTG Molecular
  • Mindray
  • Ras Lifesciences
  • MORE
PART 01: Executive summary
  • Highlights
PART 02: Scope of the report
  • Top-vendor offerings
PART 03: Market research methodology
  • Research methodology
  • Economic indicators
PART 04: Introduction
  • Key market highlights
PART 05: Companion diagnostics: Promising business model
  • Reimbursement scenario
PART 06: Perspective of LDTs in US
  • Requirement of regulatory framework
  • Post implementation scenario
PART 07: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 08: Market segmentation by application
  • Global molecular diagnostics market by infectious disease testing
  • Global molecular diagnostics market by oncological testing
  • Global molecular diagnostics market by blood testing
  • Global molecular diagnostics market by genetic testing
  • Global molecular diagnostics market by tissue typing
PART 09: Geographical segmentation
  • Molecular diagnostics market in Americas
  • Molecular diagnostics market in EMEA
  • Molecular diagnostics market in APAC
PART 10: Market drivers
  • Key to cost-effective diagnosis of cancer
  • Development of molecular POCT
  • Increase in investments in genomics and proteomics research
PART 11: Impact of drivers

PART 12: Market challenges
  • Reimbursement issues
  • Threat of low-cost products
  • Issues with quality control and cold chain management
  • Ethical issues associated with DTC genetic testing
PART 13: Impact of drivers and challenges

PART 14: Market trends
  • Growth of theranostics
  • Development of NGS technology and DNA arrays
  • Increase in partnerships
  • Development of personalized medicine
PART 15: Vendor landscape
  • Abbott Diagnostics
  • Hologic
  • Qiagen
  • Roche Diagnostics
  • Siemens Healthcare
  • Other prominent vendors
PART 16: Appendix
  • List of abbreviations
PART 17: About the Author

List of Exhibits

Exhibit 01: Product offerings
Exhibit 02: Examples of approved companion diagnostics
Exhibit 03: Companion diagnostics coverage in the US
Exhibit 04: Global molecular diagnostics market 2015-2020 ($ billions)
Exhibit 05: Five forces analysis
Exhibit 06: Segmentation of global molecular diagnostics market by application 2015
Exhibit 07: Global molecular diagnostics market by infectious disease testing 2015-2020 ($ billions)
Exhibit 08: Global molecular diagnostic market by oncological testing 2015-2020 ($ billions)
Exhibit 09: Global molecular diagnostics market by blood testing 2015-2020 ($ billions)
Exhibit 10: Global molecular diagnostics market by genetic testing 2015-2020 ($ billions)
Exhibit 11: Global molecular diagnostics market by tissue typing 2015-2020 ($ millions)
Exhibit 12: Segmentation of global molecular diagnostics market by geography 2015
Exhibit 13: Molecular diagnostics market in Americas 2015-2020 ($ billions)
Exhibit 14: Molecular diagnostics market in EMEA 2015-2020 ($ billions)
Exhibit 15: Molecular diagnostics market in APAC 2015-2020 ($ billions)
Exhibit 16: Impact of drivers
Exhibit 17: Impact of drivers and challenges
Exhibit 18: Global molecular diagnostics market by vendors 2014 and 2015
Exhibit 19: Key molecular diagnostic product launches by Roche and Qiagen 2015
Exhibit 20: Key takeaways: Abbott Diagnostics
Exhibit 21: Key takeaways: Hologic
Exhibit 22: Key takeaways: Qiagen
Exhibit 23: Key takeaways: Roche Diagnostics
Exhibit 24: Key takeaways: Siemens Healthcare
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • AsuraGen
  • EKF Molecular Diagnostics
  • HTG Molecular
  • Mindray
  • Ras Lifesciences
  • MORE
New Report Released: – Global Molecular Diagnostics Market 2016-2020

The author of the report recognizes the following companies as the key players in the Global Molecular Diagnostics Market: Abbott Laboratories, Hologic Inc., Qiagen, Roche Diagnostics (a division of F. Hoffmann-La Roche Ltd.), and Siemens Healthcare GmbH.

Other Prominent Vendors in the market are: AsuraGen, Ahram Biosystem, Analytik Jena, BD, Bio-Rad, EKF Molecular Diagnostics, EMD Millipore, HTG Molecular, InBios International, Maxim Biomedical, Mindray, Myriad Genetics, Ortho Clinical Diagnostics, Ras Lifesciences, Trivitron Healthcare, and ThermoFisher Scientific.

Commenting on the report, an analyst from the research team said: “Advances in nanotechnology and genomics have led to the development of nano-platform-based theranostics, which combines therapeutics with diagnostics and provides personalized medicine. It uses the person’s genotype for the selection of medication. It helps determine whether a certain disease is likely to respond positively to a particular treatment. Theranostics is an emerging segment in the field of IVD, with many players focusing on R&D in this segment, as it provides an opportunity to combat cancer and many other diseases.”

According to the report, cancer, a leading cause of death worldwide, can be detected early with the help of molecular diagnostic tests and is, therefore, the primary growth driver for this market. The use of molecular diagnostics will help to reduce healthcare costs for patients by avoiding unnecessary chemotherapy, medical care, and drugs. It can also be used to detect cancer biomarkers, which in turn will help to improve the survival rate of patients. The ability of molecular diagnostics to validate cancer biomarkers and improve patient care will lead to the growth of this market during the predicted period.

Further, the report states that the growth of the global molecular diagnosis market is hampered by reimbursement issues.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
- Abbott Laboratories
- Hologic Inc.
- Qiagen
- Roche Diagnostics (a division of F. Hoffmann-La Roche Ltd.)
- Siemens Healthcare GmbH
- AsuraGen
- Ahram Biosystem
- Analytik Jena
- BD
- Bio-Rad
- EKF Molecular Diagnostics
- EMD Millipore
- HTG Molecular
- InBios International
- Maxim Biomedical
- Mindray
- Myriad Genetics
- Ortho Clinical Diagnostics
- Ras Lifesciences
- Trivitron Healthcare
- ThermoFisher Scientific
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll